Stay updated on Clinical Trial: INO-3112 & Durvalumab for HPV Cancers
Sign up to get notified when there's something new on the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page.

Latest updates to the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new version is in effect. This change does not modify the displayed study data or user-facing functionality.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page revision tag changed from v3.6.3 to v3.6.4, indicating a new version of the page. This update does not specify any visible content changes.SummaryDifference0.0%

- Check43 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3, representing a new version of the page. This appears to be an internal update or patch rather than a modification to the study content.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision: v3.6.2 replaces the previous Revision: v3.6.0 on the page, indicating a version update of the display template.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page now clearly communicates that enrollment is closed and adds new user-help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also standardizes the Intervention/Treatment header and notes a revision to version 3.6.0, replacing the previous v3.5.5 reference.SummaryDifference0.5%

- Check71 days agoChange DetectedRevision label changed from v3.5.4 to v3.5.5. This indicates a minor update to the document associated with the study page.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: INO-3112 & Durvalumab for HPV Cancers
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page.